Skip to main content

Solvay strengthens its competitiveness in Germany through portfolio realignment and investments

Brussels, September 18, 2025

Solvay is taking measures to secure its long-term competitiveness in Germany. With investments and a strategic portfolio realignment, the company is positioning its Bad Wimpfen site as a global hub for NocolokⓇ production, research and application.

Solvay will discontinue selected product lines at its Bad Wimpfen site to support the company’s transformation and secure long-term value creation in a challenging market. Specifically, the company will cease production of Trifluoroacetic Acid (TFA)-related organics by early 2026 and some of its inorganics, including Hydrogen Fluoride, gradually by the end of 2026. Other product lines in Bad Wimpfen remain unaffected. As a result of this realignment, Solvay will have stopped the production of TFA and all of its derivatives across the Group by early 2026. These measures will result in a net reduction of approximately 100 positions in Bad Wimpfen.

A central element of new investments in the Bad Wimpfen site is the establishment of a state-of-the-art NocolokⓇ Paste & Paint facility, accompanied by the relocation of the NocolokⓇ Tech Center and production operations from Garbsen to Bad Wimpfen. These steps will consolidate expertise in one location and establish Bad Wimpfen as a global hub for innovation and customer applications, reinforcing Solvay’s position as a worldwide leader in automotive brazing. The measures will lead to a net reduction of around 40 positions in Garbsen. The Garbsen site is scheduled to cease operations by 2028.

Solvay is committed to managing the impact for its employees in close consultation with the employee representatives, with the clear aim of socially responsible solutions and support measures.

Solvay plans to allocate approximately €25 million – primarily in 2026 – in restructuring expenses and strategic investments.

An Nuyttens, President of Solvay’s Special Chem business stated: “Solvay remains firmly committed to Germany as an important industrial location. With our investments in Bad Wimpfen, we are sending a strong signal for our future here. By consolidating expertise, we are creating a globally leading hub for NocolokⓇ technologies while safeguarding the company’s long-term competitiveness. At the same time, we are fully aware of our social responsibility towards our employees and the competent employee representatives and will shape this transition together with them.”

Contacts

Media relations Investor relations
Peter Boelaert
+32 479 30 91 59

 

Laetitia Van Minnenbruggen
+32 484 65 30 47

 

media.relations@solvay.com

Boris Cambon-Lalanne
+32 471 55 37 49

 

Geoffroy d’Oultremont
+32 478 88 32 96

 

Vincent Toussaint
+33 6 74 87 85 65

 

investor.relations@solvay.com

About Solvay

Solvay, a pioneering chemical company with a legacy rooted in founder Ernest Solvay’s pivotal innovations in the soda ash process, is dedicated to delivering essential solutions globally through its workforce of over 9,000 employees. Since 1863, Solvay has harnessed the power of chemistry to create innovative, sustainable solutions that answer the world’s most essential needs such as purifying the air we breathe and the water we use, preserving our food supplies, protecting our health and well-being, creating eco-friendly clothing, making the tires of our cars more sustainable and cleaning and protecting our homes. Solvay’s unwavering commitment drives the transition to a carbon-neutral future by 2050, underscoring its dedication to sustainability and a fair and just transition. As a world-leading company with €4.7 billion in net sales in 2024, Solvay is listed on Euronext Brussels and Paris (SOLB). For more information about Solvay, please visit solvay.com or follow Solvay on Linkedin.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.